Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-02-20
2000-10-03
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A61K 31495, A61K 3150
Patent
active
061273678
ABSTRACT:
A method of preventing non-cardiac tissue damage resulting from ischemia, comprising administering to a patient in need of such treatment an effective amount of an aldose reductase inhibitor.
REFERENCES:
patent: 4492706 (1985-01-01), Kallai-Sanfacon
patent: 4939140 (1990-07-01), Larson et al.
patent: 5064830 (1991-11-01), Going
patent: 5391551 (1995-02-01), Peterson
patent: 5476846 (1995-12-01), Lardy et al.
CA 111:91114, Yasuda et al, 1989.
Ronald G. Tilton, et al., Diabetes, Vo. 44, Feb. 1995, "Effects of Vascular and Neural Dysfunction in Streptozocin-Induced Diabetic Rats".
Mylari B.L., et al., "Novel, potent aldose reductase inhibitors: 3,4-dihydro-4-oxo-3-([5-trifuoromethyl)-Z-benzothiazolyl] methyl-1-phthalazineacetic acid (zopolrestat) and congeners", J. Med Chem 1991 Jan.; 34 (1): 108-22.
Hosotani, H., et al., "Effects of topical aldose reductase inhbitor CT-112 on corneal sensitivity of diabetic rats", Curr-Eye-Res., 1996 Oct.; 15 (10): 10005-7.
G. Said, Neuropathies Metaboliques, 1. Diabetic Neuropathies, vol. 141, Rev. Neurol (Paris), No. 11, pp. 683-693, 1985.
David E. Price, et al., Effect of aldose Reductase Inhibition on Resistance to Ischemic Conduction Block in Diabetic Subjects, vol. 14 No. 5, Diabetes Care, pp. 411-413, May 1991.
Hitoshi Yasuda, et al., Effect of Prostaglandin E.sub.1 Analogue TFC 612 on Diabetic Neuropathy in Streptozocin-Induced Diabetic Rats, vol. 38, Diabetes, pp. 832-838, Jul. 1989.
Walter De Gruyter, Glomerukosklerose, diabetische, and Retinopathia diabetica, Pschrymbel, Klinisches, Worterbuch, p. 552 and p. 1325, 257.sup.th edition, 1994.
Roger C. Bone, et al., Gram-Negative Sepsis: A Dilemma of Modern Medicine, Clinical Microbiology Reviews, Jan. 1993, pp. 57-68, 1993, vol. 6 No. 1.
Joseph R. Williamson, et al., Hyperglycemic Pseudohypoxia and Diabetic Complicantions, vol. 42, Diabetes, pp. 801-813, Jun. 1993.
Beyer Thomas A.
Knight, Jr. Delvin R.
Mylari Banavara L.
Oates Peter J.
Pettipher E. Roy
Benson Gregg C.
Jordan Kimberly
Olson A. Dean
Pfizer Inc.
Richardson Peter C.
LandOfFree
Method of reducing tissue damage associated with non-cardiac isc does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of reducing tissue damage associated with non-cardiac isc, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of reducing tissue damage associated with non-cardiac isc will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-195784